Global artificial intelligence in healthcare market

Artificial Intelligence (AI) in Healthcare Market Size, Share, Growth Analysis, By Component(Hardware, Services, and Software), By Technology(Machine Learning, Natural Language Processing, Context-aware Computing, and Computer Vision), By Application(Robot-assisted Surgery, Virtual Assistants, Administrative Workflow Assistants, Clinical Trials), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35G2090 | Region: Global | Published Date: July, 2024
Pages: 219 | Tables: 143 | Figures: 77

Artificial Intelligence (AI) in Healthcare Market Dynamics

Artificial Intelligence In Healthcare Market Drivers

Improved Diagnostic Accuracy and Generalized Medication 

  • Artificial intelligence (AI) in healthcare dramatically increases diagnostic accuracy by analyzing large amounts of medical data, including medical imaging, genetic data, and patient records. AI systems can identify patterns and abnormalities that might be missed by human doctors, leading to faster and more accurate diagnoses. Furthermore, AI enables personalized medicine by developing treatment regimens based on individual patient data, improving patient outcomes and reducing side effects. This capability is especially impressive in industry hear as in oncology, cardiology, and neurology. 

Increasing Efficiency and Operating Costs  

  • AI technologies are streamlining business and clinical operations in healthcare, increasing efficiency and reducing operating costs. Automation of routine tasks such as scheduling, billing and data entry frees healthcare professionals to focus on patient care. Additionally, AI-powered predictive analytics can optimize resource allocation, reduce hospital readmissions, and improve supply chain management. These efficiencies improve care quality and contribute to significant cost savings for health care providers. 

Restraints 

High Implementation Costs and Technical Difficulties 

  • The adoption of AI in healthcare requires significant initial investment in technology, infrastructure and training. Developing and integrating AI solutions into existing healthcare systems can be technically complex and resource intensive. Smaller healthcare providers, especially those in rural or underserved areas, may struggle with financial and technical barriers to implementing AI technologies. These high costs and challenges may limit the adoption of AI in healthcare has been slow in the process. 

Data Privacy and Security Issues 

  • AI in healthcare relies heavily on the availability and use of vast critical patient data. Ensuring the privacy and security of this data is a major challenge. Patient data breaches can raise serious legal and ethical issues, undermining trust in AI technology. Additionally, regulatory frameworks such as HIPAA (Health Insurance Portability and Accountability Act) in the US impose stringent requirements on data processing, which can complicate the implementation of AI solutions. Addressing these privacy and security concerns is crucial for the sustainable development of the market.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Artificial Intelligence in Healthcare Market size was valued at USD 14.09 billion in 2022 and is poised to grow from USD 19.47 billion in 2023 to USD 259.11 billion by 2031, growing at a CAGR of 38.2% during the forecast period (2024-2031).

The global artificial intelligence in the healthcare market is experiencing robust growth, driven by factors such as the increasing need for efficient healthcare solutions, rising investments in AI technology by key players, and supportive government initiatives. Major players in the market are actively engaged in strategic partnerships, mergers, and acquisitions to expand their product portfolios and strengthen their market presence. Additionally, advancements in AI technology, particularly in areas such as medical imaging analysis, predictive analytics, and personalized treatment planning, are further propelling market growth. 'Microsoft Corporation  ', 'Alphabet Inc.  ', 'NVIDIA Corporation  ', 'General Vision, Inc.  ', 'Intel Corporation  ', 'IBM Corporation  ', 'Welltok, Inc.  ', 'General Electric Company ', 'Verint Systems Inc.  ', 'Bolton NHS Foundation Trust  ', 'Qure.ai  ', 'THIRONA   ', 'Koninklijke Philips N V. ', 'Siemens Healthineers  ', 'Lunit Inc ', 'Biobeat   ', 'Ginger Recruitment ', 'Sirona Medical, Inc. ', 'Qventus Inc ', 'Stryker'

Artificial intelligence (AI) in healthcare dramatically increases diagnostic accuracy by analyzing large amounts of medical data, including medical imaging, genetic data, and patient records. AI systems can identify patterns and abnormalities that might be missed by human doctors, leading to faster and more accurate diagnoses. Furthermore, AI enables personalized medicine by developing treatment regimens based on individual patient data, improving patient outcomes and reducing side effects. This capability is especially impressive in industry hear as in oncology, cardiology, and neurology. 

Impact of Chronic Disease Prevalence on Adoption of AI in Healthcare: The escalating prevalence of chronic diseases, coupled with significant product launches by industry players, is a driving force in the healthcare segment.     For instance, the Cancer Facts and Figures 2022 report released by the American Cancer Society in January 2022 projected nearly 1.9 million new cancer cases in 2022 alone. This forecast included estimates of 186,670 prostate cancer cases, 169,870 lung cancer cases, and 144,490 female breast cancer cases. The rising incidence of cancer and other chronic ailments underscores the pressing need for precise diagnosis and treatment solutions. Consequently, there's a growing demand for AI-driven technologies aimed at facilitating early disease detection, thus propelling market growth in the healthcare sector.

The surge in artificial intelligence adoption within the North America region is fueled by several key factors, including the increasing integration of advanced technology into healthcare systems, heightened investment in AI-based startups, the escalating burden of chronic diseases, and the imperative to curtail healthcare expenditures, alongside the widespread implementation of big data in healthcare. The escalating uptake of big data in healthcare within the region is poised to propel market expansion further. For Instance, in August 2022, the Children's Hospital of Philadelphia (CHOP) and the University of Pennsylvania School of Medicine (Penn Medicine) jointly inaugurated the Penn-CHOP Kidney Innovation Center, leveraging big data to bolster research aimed at enhancing patient care for individuals, both adults, and children, grappling with kidney disease.  

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global artificial intelligence in healthcare market

Report ID: SQMIG35G2090

$5,300
BUY NOW GET FREE SAMPLE